Kiromic Biopharma Inc Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their KRBP stock forecasts and price targets.

Forecast return on equity

Is KRBP forecast to generate an efficient return?
Insufficient data to display

Forecast return on assets

Is KRBP forecast to generate an efficient return on assets?
KRBP is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

KRBP vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
DRMA$1.62$4.00+146.91%Strong Buy

Kiromic Biopharma Stock Forecast FAQ

What is KRBP's forecast return on equity (ROE) for 2023-2024?

(NASDAQ: KRBP) forecast ROE is N/A, which is considered weak.

If you're new to stock investing, here's how to buy Kiromic Biopharma stock.

What is KRBP's forecast return on assets (ROA) for 2023-2024?

(NASDAQ: KRBP) forecast ROA is -446.04%, which is lower than the forecast US Biotechnology industry average of -0.57%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.